Artículos con órdenes de acceso público - Michael AshtonMás información
No disponibles en ningún lugar: 4
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 …
D Röshammar, USH Simonsson, H Ekvall, L Flamholc, V Ormaasen, ...
Journal of pharmacokinetics and pharmacodynamics 38, 727-742, 2011
Órdenes: Swedish Research Council
Mono-, di-and trisubstituted derivatives of eflornithine: synthesis for in vivo delivery of DL-α-difluoromethyl-ornithine in plasma
TT Cloete, CC Johansson, DND David, SK Vodnala, ME Rottenberg, ...
Arzneimittelforschung 61 (05), 317-325, 2011
Órdenes: Swedish Research Council
Effects of oral administration of synthesized δ-amides of eflornithine in the rat
KJ Helena, DD N’Da, CC Johansson, JC Breytenbach, M Ashton
Arzneimittelforschung 60 (11), 682-688, 2010
Órdenes: Swedish Research Council
Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects
MM Thapar, J Ursing, M Ashton, Y Bergqvist, JP Gil, A Björkman
Journal of Travel Medicine 29 (4), taac058, 2022
Órdenes: Swedish Research Council
Disponibles en algún lugar: 16
Neural correlates of the DMT experience assessed with multivariate EEG
C Timmermann, L Roseman, M Schartner, R Milliere, LTJ Williams, ...
Scientific reports 9 (1), 16324, 2019
Órdenes: UK Medical Research Council, National Institute for Health Research, UK
Artemether‐lumefantrine co‐administration with antiretrovirals: population pharmacokinetics and dosing implications
RM Hoglund, P Byakika‐Kibwika, M Lamorde, C Merry, M Ashton, ...
British journal of clinical pharmacology 79 (4), 636-649, 2015
Órdenes: Health Research Board, Ireland, Wellcome Trust
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: a pharmacokinetic-pharmacodynamic meta-analysis
F Kloprogge, L Workman, S Borrmann, M Tékété, G Lefèvre, K Hamed, ...
PLoS medicine 15 (6), e1002579, 2018
Órdenes: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers
S Birgersson, P Van Toi, NT Truong, NT Dung, M Ashton, TT Hien, ...
Malaria journal 15, 1-10, 2016
Órdenes: Wellcome Trust
Psychological and physiological effects of extended DMT
LX Luan, E Eckernäs, M Ashton, FE Rosas, MV Uthaug, A Bartha, ...
Journal of Psychopharmacology 38 (1), 56-67, 2024
Órdenes: National Institute for Health Research, UK
Model‐based assessment of variability in isoniazid pharmacokinetics and metabolism in patients co‐infected with tuberculosis and HIV: implications for a novel dosing strategy
J Sundell, E Bienvenu, D Janzén, S Birgersson, A Äbelö, M Ashton
Clinical Pharmacology & Therapeutics 108 (1), 73-80, 2020
Órdenes: Knut and Alice Wallenberg Foundation, Swedish Research Council
Bilirubin—a potential marker of drug exposure in atazanavir-based antiretroviral therapy
D Rekić, O Clewe, D Röshammar, L Flamholc, A Sönnerborg, ...
The AAPS journal 13, 598-605, 2011
Órdenes: Swedish Research Council
PXR Variants and Artemisinin Use in Vietnamese Subjects: Frequency Distribution and Impact on the Interindividual Variability of CYP3A Induction by Artemisinin
R Piedade, E Schaeffeler, S Winter, S Asimus, M Schwab, M Ashton, ...
Antimicrobial agents and chemotherapy 56 (4), 2153-2157, 2012
Órdenes: German Research Foundation
Population pharmacokinetics and pharmacogenetics of ethambutol in adult patients coinfected with tuberculosis and HIV
J Sundell, E Bienvenu, S Birgersson, A Äbelö, M Ashton
Antimicrobial Agents and Chemotherapy 64 (2), 10.1128/aac. 01583-19, 2020
Órdenes: Knut and Alice Wallenberg Foundation, Swedish Research Council
MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy
K Vos, CL Sciuto, R Piedade, M Ashton, A Björkman, B Ngasala, ...
Pharmacogenomics 18 (10), 981-985, 2017
Órdenes: Swedish Research Council
Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
M Boberg, AC Jonson, H Leek, R Jansson-Löfmark, M Ashton
ACS omega 5 (37), 23885-23891, 2020
Órdenes: Swedish Research Council
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV
J Sundell, E Bienvenu, A Äbelö, M Ashton
Journal of Antimicrobial Chemotherapy 76 (11), 2950-2957, 2021
Órdenes: Knut and Alice Wallenberg Foundation, Swedish Research Council
Enantiospecific antitrypanosomal in vitro activity of eflornithine
M Boberg, M Cal, M Kaiser, R Jansson-Löfmark, P Mäser, M Ashton
PLoS Neglected Tropical Diseases 15 (7), e0009583, 2021
Órdenes: Swedish Research Council
Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy …
C Amilon, M Boberg, J Tarning, A Äbelö, M Ashton, R Jansson-Löfmark
The AAPS journal 24 (3), 48, 2022
Órdenes: Swedish Research Council, Wellcome Trust
External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
D Rekić, D Röshammar, M Bergstrand, J Tarning, A Calcagno, A D’Avolio, ...
The AAPS journal 15, 308-315, 2013
Órdenes: Swedish Research Council, Wellcome Trust
Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients
J Sundell, E Bienvenu, S Birgersson, A Äbelö, M Ashton
Antimicrobial Agents and Chemotherapy 66 (10), e02277-21, 2022
Órdenes: Knut and Alice Wallenberg Foundation, Swedish Research Council
La información de publicación y financiación se determina de forma automática mediante un programa informático